SG11201504286VA - Transdermal delivery system - Google Patents
Transdermal delivery systemInfo
- Publication number
- SG11201504286VA SG11201504286VA SG11201504286VA SG11201504286VA SG11201504286VA SG 11201504286V A SG11201504286V A SG 11201504286VA SG 11201504286V A SG11201504286V A SG 11201504286VA SG 11201504286V A SG11201504286V A SG 11201504286VA SG 11201504286V A SG11201504286V A SG 11201504286VA
- Authority
- SG
- Singapore
- Prior art keywords
- delivery system
- transdermal delivery
- transdermal
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261736342P | 2012-12-12 | 2012-12-12 | |
| PCT/EP2013/076325 WO2014090921A1 (en) | 2012-12-12 | 2013-12-12 | Transdermal delivery system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201504286VA true SG11201504286VA (en) | 2015-06-29 |
Family
ID=49816915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201504286VA SG11201504286VA (en) | 2012-12-12 | 2013-12-12 | Transdermal delivery system |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US20150306093A1 (en) |
| EP (1) | EP2931263A1 (en) |
| JP (1) | JP2016502989A (en) |
| KR (1) | KR20150096460A (en) |
| CN (1) | CN105007906A (en) |
| AP (1) | AP2015008525A0 (en) |
| AR (1) | AR093940A1 (en) |
| AU (1) | AU2013205080B2 (en) |
| BR (1) | BR112015013660A2 (en) |
| CA (1) | CA2894960A1 (en) |
| CL (1) | CL2015001577A1 (en) |
| CR (1) | CR20150360A (en) |
| DE (1) | DE112013005945T5 (en) |
| EA (1) | EA201591124A1 (en) |
| GB (1) | GB2523715A (en) |
| HK (1) | HK1215677A1 (en) |
| IL (1) | IL239223A0 (en) |
| MX (1) | MX2015007348A (en) |
| NZ (1) | NZ628092A (en) |
| PE (1) | PE20151147A1 (en) |
| PH (1) | PH12015501169A1 (en) |
| SG (1) | SG11201504286VA (en) |
| TN (1) | TN2015000201A1 (en) |
| TW (1) | TW201438765A (en) |
| WO (1) | WO2014090921A1 (en) |
| ZA (1) | ZA201504964B (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102006054731B4 (en) | 2006-11-21 | 2013-02-28 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system for administration of the active ingredient buprenorphine and use thereof in pain therapy |
| EA201491164A1 (en) | 2011-12-12 | 2014-10-30 | ЭлТиЭс ЛОМАНН ТЕРАПИ-ЗЮСТЕМ АГ | TRANSDERMAL SYSTEM SUPPLIES |
| WO2014195352A1 (en) | 2013-06-04 | 2014-12-11 | Lts Lohmann Therapie-Systeme Ag | Transdermal delivery system |
| US10406152B2 (en) | 2015-03-10 | 2019-09-10 | Rhodes Technologies | Acetate salt of buprenorphine and methods for preparing buprenorphine |
| EP3349737A4 (en) * | 2015-09-14 | 2019-05-15 | Amneal Pharmaceuticals LLC | Transdermal delivery system |
| KR101695603B1 (en) * | 2016-11-08 | 2017-01-12 | 이창우 | needle disc roller apparatus comprising viscoelastic connection cap with structures being tightly joined to lower end of a bottle neck |
| WO2019064026A1 (en) | 2017-09-29 | 2019-04-04 | Orexo Ab | New pharmaceutical compositions |
| WO2019175096A1 (en) * | 2018-03-13 | 2019-09-19 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system for the transdermal administration of buprenorphine comprising a silicone acrylic hybrid polymer |
| JP2021515789A (en) * | 2018-03-13 | 2021-06-24 | エルテーエス ローマン テラピー−ジステーメ アーゲー | Transdermal treatment system containing silicone acrylic hybrid polymer |
| CN111971033A (en) * | 2018-03-13 | 2020-11-20 | 罗曼治疗系统股份公司 | Transdermal therapeutic system comprising silicone acrylic hybrid polymers |
| US20210038532A1 (en) * | 2018-03-13 | 2021-02-11 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system comprising a silicone acrylic hybrid polymer |
| GB201904767D0 (en) | 2019-04-04 | 2019-05-22 | Orexo Ab | New pharmaceutical compositions |
| WO2021005117A1 (en) * | 2019-07-09 | 2021-01-14 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system comprising an active agent-containing layer comprising a silicone-containing polymer and a skin contact layer comprising a silicone gel adhesive |
| CN113952319A (en) * | 2021-11-30 | 2022-01-21 | 烟台大学 | Skeleton type transdermal patch containing buprenorphine and preparation method thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968547A (en) * | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| EP1572167B1 (en) * | 2002-12-13 | 2008-07-09 | Euro-Celtique S.A. | Transdermal buprenorphine dosage regimen for analgesia |
| CN1943576A (en) * | 2006-10-27 | 2007-04-11 | 哈尔滨健迪医药技术有限公司 | Buprenorphin and/or buprenorphin hydrochloride plaster substrate and its preparing method for plaster |
| DE102006054731B4 (en) * | 2006-11-21 | 2013-02-28 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system for administration of the active ingredient buprenorphine and use thereof in pain therapy |
| CN101612141B (en) * | 2009-07-29 | 2012-10-03 | 考司美德制药株式会社 | Buprenorphine patch |
-
2013
- 2013-04-13 AU AU2013205080A patent/AU2013205080B2/en not_active Ceased
- 2013-12-12 JP JP2015547016A patent/JP2016502989A/en not_active Abandoned
- 2013-12-12 CA CA2894960A patent/CA2894960A1/en not_active Abandoned
- 2013-12-12 MX MX2015007348A patent/MX2015007348A/en unknown
- 2013-12-12 WO PCT/EP2013/076325 patent/WO2014090921A1/en active Application Filing
- 2013-12-12 CN CN201380071638.8A patent/CN105007906A/en active Pending
- 2013-12-12 SG SG11201504286VA patent/SG11201504286VA/en unknown
- 2013-12-12 EP EP13810924.4A patent/EP2931263A1/en not_active Withdrawn
- 2013-12-12 AP AP2015008525A patent/AP2015008525A0/en unknown
- 2013-12-12 PE PE2015000906A patent/PE20151147A1/en not_active Application Discontinuation
- 2013-12-12 AR ARP130104652A patent/AR093940A1/en unknown
- 2013-12-12 NZ NZ628092A patent/NZ628092A/en not_active IP Right Cessation
- 2013-12-12 KR KR1020157018513A patent/KR20150096460A/en not_active Application Discontinuation
- 2013-12-12 BR BR112015013660A patent/BR112015013660A2/en active Search and Examination
- 2013-12-12 EA EA201591124A patent/EA201591124A1/en unknown
- 2013-12-12 TW TW102145867A patent/TW201438765A/en unknown
- 2013-12-12 DE DE112013005945.2T patent/DE112013005945T5/en not_active Withdrawn
- 2013-12-12 US US14/650,451 patent/US20150306093A1/en not_active Abandoned
- 2013-12-12 GB GB1512243.5A patent/GB2523715A/en not_active Withdrawn
-
2015
- 2015-05-22 TN TNP2015000201A patent/TN2015000201A1/en unknown
- 2015-05-26 PH PH12015501169A patent/PH12015501169A1/en unknown
- 2015-06-04 IL IL239223A patent/IL239223A0/en unknown
- 2015-06-08 CL CL2015001577A patent/CL2015001577A1/en unknown
- 2015-07-09 CR CR20150360A patent/CR20150360A/en unknown
- 2015-07-10 ZA ZA2015/04964A patent/ZA201504964B/en unknown
-
2016
- 2016-03-30 HK HK16103661.4A patent/HK1215677A1/en unknown
-
2018
- 2018-03-08 US US15/915,369 patent/US20180193333A1/en not_active Abandoned
-
2020
- 2020-04-30 US US16/863,584 patent/US20200253957A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL239223A0 (en) | 2015-07-30 |
| AP2015008525A0 (en) | 2015-06-30 |
| CN105007906A (en) | 2015-10-28 |
| TN2015000201A1 (en) | 2016-10-03 |
| US20180193333A1 (en) | 2018-07-12 |
| AU2013205080B2 (en) | 2016-07-07 |
| WO2014090921A1 (en) | 2014-06-19 |
| US20200253957A1 (en) | 2020-08-13 |
| EP2931263A1 (en) | 2015-10-21 |
| HK1215677A1 (en) | 2016-09-09 |
| DE112013005945T5 (en) | 2015-08-27 |
| GB2523715A (en) | 2015-09-02 |
| PE20151147A1 (en) | 2015-08-06 |
| TW201438765A (en) | 2014-10-16 |
| GB201512243D0 (en) | 2015-08-19 |
| AU2013205080A1 (en) | 2014-06-26 |
| AR093940A1 (en) | 2015-07-01 |
| PH12015501169A1 (en) | 2015-08-10 |
| MX2015007348A (en) | 2016-01-20 |
| BR112015013660A2 (en) | 2017-07-11 |
| NZ628092A (en) | 2017-01-27 |
| CR20150360A (en) | 2015-08-21 |
| ZA201504964B (en) | 2017-11-29 |
| EA201591124A1 (en) | 2015-11-30 |
| US20150306093A1 (en) | 2015-10-29 |
| KR20150096460A (en) | 2015-08-24 |
| JP2016502989A (en) | 2016-02-01 |
| CL2015001577A1 (en) | 2015-10-02 |
| CA2894960A1 (en) | 2014-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2512007B (en) | Transdermal delivery system | |
| HK1222135A1 (en) | Transdermal delivery system | |
| HK1215677A1 (en) | Transdermal delivery system | |
| GB201215193D0 (en) | Order delivery system | |
| GB2503668B (en) | Delivery apparatus | |
| EP2812069A4 (en) | Transdermal delivery device | |
| ZA201406682B (en) | Transdermal delivery devices | |
| EP2858712A4 (en) | Radiopharmacuetical delivery device | |
| EP2806940A4 (en) | Delivery device | |
| RS56833B1 (en) | Transdermal delivery system | |
| GB201421723D0 (en) | Delivery device | |
| GB201213846D0 (en) | Location system | |
| GB201217418D0 (en) | System | |
| GB201213491D0 (en) | Content delivery system | |
| EP2904178A4 (en) | Retaining system | |
| SG10201609440WA (en) | Multi-additive delivery system | |
| EP2874940A4 (en) | Liquid delivery system | |
| SG11201405743QA (en) | Liposomal delivery system | |
| HK1204287A1 (en) | Transdermal hormone delivery | |
| GB201214708D0 (en) | Secure delivery system | |
| ZA201301760B (en) | Transdermal delivery devices | |
| GB201220308D0 (en) | Passerelle system | |
| GB201220256D0 (en) | Ourtizanz system | |
| GB201108399D0 (en) | Secure delivery system | |
| GB201219191D0 (en) | Mc-mat system |